RE:PGX ahead of scheduleGagnon is betting shareholders' money that PGX-YBG can take market share from incumbents. It may have superior properties but it also costs more to manufacture due to the large capex PGX plants. So will consumers pay more for a premium product or does CZO earn thinner margins? Where's the market reseacrh to back up Gagnon's bet? Recall the BG pill failure.